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Human mesangial cells express inducible macrophage scaven- ing acetylated low-density lipoprotein (Ac-LDL) and ox-
ger receptor. idized low-density lipoprotein (Ox-LDL) [1–3]. Two types
Background. Type A scavenger receptors (Scr) mediate the of scavenger receptors have been identified. The first of
uptake of modified low-density lipoproteins by macrophages.
these to be purified and cloned was the type A scavengerThe accumulation of lipids via this process is thought to lead
receptors (Scr) [4]. Subsequently, the CD36 cell surfaceto foam cell formation in atherosclerotic plaques. Human mes-
angial cells (HMCs) have not been previously shown to express protein family was shown to bind Ox-LDL and was de-
Scr in normal culture. We therefore investigated whether there fined as type B scavenger receptors [5]. Unlike the LDL
is an inducible form of Scr in a human mesangial cell line receptor, the activity of Scr is not suppressed by rising
(HMCL).
intracellular cholesterol concentration, thus providing aMethods. Scr activity was analyzed by cellular uptake of
mechanism for unregulated cholesterol uptake. Two iso-fluorescently labeled acetylated low-density lipoprotein using
forms of the Scr (type A-I and A-II) represent late genea flow cytometer. Scr mRNA expression was examined using
reverse transcription-polymerase chain reaction, followed by products that are highly restricted to macrophages and
Southern blotting. To investigate the molecular mechanism of that are related cell types in their pattern of expression
Scr expression, several reporter gene constructs were designed. [6]. A single gene that gives rise to an alternatively splicedThe first contained a full Scr promoter, the second a part of
primary transcript encodes these two forms of the Scrthe Scr promoter that has both AP-1 and ets transcription
[7, 8]. Although their normal physiological role remainsfactor binding sites. Other constructs were identical to the
second, except that they contained either AP-1 or ets motif uncertain, biochemical studies have demonstrated that
mutations. both isoforms of Scr are capable of binding and inter-
Results. Phorbol 12-Myristate 13-acetate (PMA) and angio- nalizing Ac-LDL and Ox-LDL [7, 9]. Nonmacrophagetensin II (Ang II) increased both the percentage of Scr-positive
cells transfected with cDNAs encoding Scr accumulatecells and the Scr mean fluorescence intensity. PMA and Ang
cholesterol and develop foam cell characteristics whenII also increased Scr mRNA and promoter activity in a time-
and dose-responsive manner. Protein kinase C and calmodulin incubated with modified LDL, whereas mock-transfected
transduction pathways were involved in Scr up-regulation in- cells do not [9]. These findings suggest that the expression
duced by PMA and Ang II. Additionally, a serine/threonine of Scr protein might be both necessary and sufficient tokinase was involved in PMA stimulation. Functional analysis
account for foam cell formation in vivo. On the basis ofshowed that both AP-1 and ets motifs were specific response
their ability to internalize and degrade Ox-LDL, Scr alsoelements to PMA stimulation in HMCLs.
Conclusions. This study suggests that HMCs may express appears to provide a mechanism for the development of
an inducible Scr, by which cells can acquire lipids and convert cholesterol-engorged mesangial cells.
to foam cells in developing glomerulosclerosis. Previous studies characterizing the expression of Scr
on human mesangial cells (HMCs) have been conflicting.
In vitro, Gro¨ne et al reported that Ac-LDL and Ox-LDL
Scavenger receptors are integral membrane proteins were not taken up specifically, suggesting no active Scr
that bind and internalize a broad array of ligands, includ- in cultures of HMCs [10]. Lee and Koh also reported that
there was very low Ox-LDL binding and internalizing
activity in normal cultures of HMCs compared with ratKey words: glomerulosclerosis, gene transcription regulation, foam
cells, lipids, atherosclerotic plaque. mesangial cells [11]. However, Takemura et al demon-
strated Scr on the membranes of mesangial cells of renalReceived for publication June 23, 1998
biopsy tissues from patients with several types of glomer-and in revised form February 22, 1999
Accepted for publication March 1, 1999 ular diseases and that the Scr expression was increased
in glomeruli with marked mesangial proliferation [12]. 1999 by the International Society of Nephrology
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One explanation for these discrepancies is that growth Cell labeling for flow cytometry
conditions in culture led to alterations in Scr gene expres- The use of DiI-Ac-LDL as a fluorescent probe to de-
sion that would not occur in vivo. Accordingly, there tect Scr protein expression is an established method in
may be inducible expression of Scr in HMCs. studies of lipoprotein–receptor interactions and athero-
Phorbol 12-myristate 13-acetate (PMA), which acti- sclerosis [22, 23]. HMCLs were cultured in serum-free
vates the protein kinase C (PKC) pathway, induces dif- medium containing 16 nmol/liter PMA or 1 mmol/liter
ferentiation of human THP-1 monocytic cells into macro- Ang II for various times before the addition of 10 mg/
phages, and both Scr activity and Scr mRNA appear to ml of DiI-Ac-LDL in the presence or absence of a 100-
fold excess of unlabeled Ac-LDL at 378C. After threebe up-regulated during this transformation [13]. AP-1
hours, the cells were detached from the plates by incuba-and ets (AP-1/ets) transcription factors are necessary for
tion with 0.5% trypsin-ethylenediaminetetraacetic acidScr induction by PMA [14]. Angiotensin II (Ang II) is
(EDTA) and were fixed in 5% formalin solution in phos-known to activate PKC in HMCs and has been shown
phate-buffered saline (PBS). Each experiment was car-to possess atherogenic properties [15, 16]. It increases
ried out in duplicate.the activity of the macrophage Scr, enhances macrophage
lipid peroxidation both in vivo and in vitro, and also binds
Flow cytometry analysis
to LDL, forming modified LDL, which is taken up by
The fixed cells were washed three times in PBS andmacrophage Scr at an enhanced rate [17]. These studies
were analyzed by fluorescence-activated cell sorter anal-suggest that Ang II may have an additional effect in the
ysis (FACS) using a flow cytometer (EPICS XL-MCL;development of atherosclerosis, which is independent of
Coulter, Hialeah, FL, USA). Forward angle and 908its hypertensive action. As HMCs exhibit macrophage-
light-scatter gates were established to exclude dead cellslike function, this study was undertaken to determine
and cell debris from analysis. Fluorescence signals fromwhether PMA and Ang II could induce Scr expression
the accumulated DiI in the cells were collected at 555
in HMCs, and to investigate the role of AP-1/ets tran- to 600 nm by a photomultiplier, converted to digital
scription factors in Scr expression. format, and processed for storage and display in one-
parameter, log scale frequency histograms. Five thou-
sand cells were analyzed in each sample. The data wereMETHODS
evaluated by two parameters of the histograms: the per-
Cell culture centages of DiI-labeled positive cells and the mean fluo-
An established stable HMC line (HMCL) was used rescence intensity (MFI). Autofluorescence signals from
in all experiments (kindly donated by Dr. J.D. Sraer, unlabeled cells were used as negative controls in each
Hoˆpital Tenon, Paris, France). HMCs were immortalized experiment. The percentage of DiI-labeled positive cells
by transfection with T-SV40 and H-ras oncogene. It re- was calculated by counting labeled cells that exceeded
tains many morphological and physiological features of the upper limit of the autofluorescence of unlabeled cells.
The MFI of DiI-labeled cells was calculated by sub-normal HMCs [18, 19]. HMCLs were cultured in growth
tracting the autofluorescence intensity from the observedmedium containing RPMI, 5% fetal calf serum (FCS),
MFI of labeled cells. The average of the duplicate deter-2 mmol/liter glutamine, 10 5 unit/liter penicillin, 0.1
mination was used for statistical analyses.g/liter streptomycin, 2.5 3 103 g/liter amphotericin, 5 3
1023 g/liter insulin, 5 3 1023 g/liter human transferrin,
Establishment of a stable cell line expressing a high
and 5 3 1026 g/liter sodium selenite. Experiments were level of Scr
carried out in serum-free RPMI medium containing
Human mesangial cell lines were transfected with ex-0.2% bovine serum albumin (BSA; Sigma, Poole, Dorset,
pressive vector pXhSR1, which contains cDNA encodingUK). All reagents for cell culture were obtained from
Scr (kindly donated by Dr. Kodama, University ofGIBCO BRL (Paisley, UK).
Tokyo, Tokyo, Japan) using SuperFect Reagent (Qia-
gen, Crawley, West Sussex, UK). Two days after trans-Preparation of acetylated lipoprotein
fection, G418 was added to a final concentration (400
Plasma was collected from healthy human volunteers. mg/ml), and resistant cells were selected over two weeks.
LDL was isolated by sequential ultracentrifugation [20] Transfected cells (HMCL-Scr) expressing high levels of
and was acetylated (Ac-LDL) by the method as de- Scr activity were detected using reverse transcription-
scribed by Innerarity, Pitas and Mahley [21]. Ac-LDL polymerase chain reaction (RT-PCR) and FACS.
was passed through a 0.2 mm filter before use and was HMCL-Scr were subjected to morphological studies.
not used beyond 10 days. Ac-LDL labeled with 1,19-
Morphological examinationdioctadecyl-3,3,39,39,-tetramethylindocarbocyanine per-
chlorate (DiI-Ac-LDL) was obtained from Biogenesis Human mesangial cell lines or HMCL-Scr were plated
in chamber slides for tissue culture (Nunc Inc., Naper-(Poole, UK).
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Fig. 1. Scavenger receptor (Scr) promoter
and reporter gene constructs used in this
study. (A) The Scr 59 upstream region. (B)
The nucleotide sequences of the Scr promoter
AP-1/ets motifs. (C and D) Corresponding se-
quences containing mutations in the AP-1 or
ets. (E) Reporter gene construct (ESL) con-
taining the full Scr promoter (2696 to 146)
and luciferase gene. (F ) A minimal reporter
gene construct of the minimal prolactin gene
promoter and luciferase gene. (G) Reporter
gene constructs that contain minimal reporter
gene plus one or three copies of AP-1 or ets
motifs with or without mutations.
ville, IL, USA) and incubated in serum-free RPMI me- Applied Biosystems Ltd., Warrington, Cheshire, UK).
dium or serum-free medium in the presence of 16 nmol/ The RT reaction was set up in a 20 ml mixture containing
liter PMA or 1 mmol/liter Ang II. After 72 hours of 50 mmol/liter KCl, 10 mmol/liter Tris/HCl, 5 mmol/liter
incubation, the cells were further incubated with 50 mg/ MgCl2, 1 mmol/liter of each dNTPs, 2.5 mmol/liter ran-
ml Ac-LDL for 48 hours at 378C. The cells were washed dom hexamers, 20 U RNAsin, and 50 U of M-MLV re-
three times with PBS, fixed for 30 minutes with 5% verse transcriptase. Incubations were performed in a DNA
formalin solution in PBS, stained with Oil Red O for Thermal Cycler (Perkin-Elmer 9600) for 10 minutes at
30 minutes, and counterstained with hematoxylin for room temperature, followed by 30 minutes at 428C and
another 5 minutes. Finally, the cells were examined by 5 minutes at 998C. After cDNA synthesis by RT, the
light microscopy. For fluorescence microscopy, both incubation mixture was split into two 10 ml aliquots for
HMCLs and primary cultures of HMCs treated with 16 separate amplification of the Scr cDNA and the GAPDH
nmol/liter PMA for 72 hours were incubated for 14 hours
cDNA using specific primers: Scr 59 primer (nucleotidewith 1 mmol/liter of colchicine to synchronize popula-
position 75 to 94), TCGCTCAATGACAGCTTTGC; 39tions and then cultured for 5 hours with 10 mg/ml of DiI-
primer (nucleotide position 345 to 364), CCATGTTGCAc-LDL at 378C. The cells were then washed in PBS
TCATGTGTTCC [4]; GAPDH, 59 primer (nucleotideand fixed in 5% formalin solution in PBS. Slides were
position 73-92) TCATAGACAAGATGGTGAAG; 39examined on a Leitz fluorescence microscope.
primer (nucleotide position 303-327), TGACGGGATC
Reverse transcription-polymerase chain reaction TCGCTCCTGGAAGAT [24]. For PCR, the final con-
centrations of the 50 ml PCR reaction mixture were 50Total RNA (500 ng) was used as a template for RT-
PCR. All reagents were obtained from Perkin-Elmer (PE mmol/liter KCl, 10 mmol/liter Tris/HCl, 2 mmol/liter
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probed with [g-32P]ATP (3000 Ci/mmol; Amersham, Little
Chalfont, Buckinghamshire, UK)-labeled oligonucleo-
tides: Scr probe (nucleotide position 128-157), GTGCA
GCTTTGAAGGACTTCAGTTTCTCTT [4]; GAPDH
probe (nucleotide position 170-191), AATGAAGGGG
TCGTTGATGGCA [24]. The DNA probes were la-
beled using the 59-end labeling system (Promega, South-
ampton, Hampshire, UK). Membranes were irradiated
by ultraviolet stratalinker for three minutes, prehybrid-
ized in 50% formamide, 5X Denhardt’s solution, 5X
SSPE, 100 mg/ml herring sperm (hs) DNA, 50 mmol/
liter sodium phosphate (pH 6.8) at 428C for four hours,
and hybridized overnight at 428C with at least 1 3 106
cpm/ml of the labeled probe in the same solution as for
prehybridization but without Denhardt’s reagents. The
membranes were washed twice for 15 minutes at room
temperature with 5X SSC and then washed for 10 minutes
at 428C with 5X SSC. The blots were exposed to x-ray
films (Kodak, Rochester, NY, USA) for four hours. The
relative radiation density (the ratio of Scr to GAPDH)
was calculated for each sample to adjust for the differ-
ences in RNA mass between templates and was used for
the quantitative comparisons.
Plasmid constructs
To determine the molecular mechanisms responsible
for PMA and Ang II-dependent Scr transcriptional acti-
vation in HMC, the Scr promoter-luciferase fusion gene
ESL was constructed. This contains Scr promoter 59 up-
stream (2696 to 146) from the Scr gene (Fig. 1) [14].
The 59 upstream of Scr gene (24.5kb to 146) was found
to lack a conventional TATA box and initiated transcrip-
tion from a cluster of closely spaced start sites. These
Fig. 2. Analysis of the percentage of DiI-labeled cells and the mean sequence motifs include three near consensus transcrip-
fluorescence intensity (MFI) in the phorbol 12-myristate 13-acetate tion factor AP-1 binding sites (AP-1 motifs), two of(PMA) and angiotensin II (Ang II) treated-human mesangial cell lines
which are juxtaposed with binding sites for members of(HMCLs). HMCLs were incubated in serum-free medium with 16 nmol/
liter of PMA (d) or 1 mmol/liter of Ang II (j) for 0, 24, 48, and 72 the transcription factor ets family (ets motifs) [13, 14].
hours, respectively. Then the medium was replaced by fresh serum-free To further examine the relative roles of the AP-1 andmedium containing 10 mg/ml DiI-labeled Ac-LDL for three hours at
ets (AP-1/ets) motifs in mediating PMA and Ang II-378C. The cells were analyzed by fluorescence-activated cell sorter anal-
ysis (FACS). The percentage of DiI-labeled cells was calculated by dependent transcriptional activation, luciferase reporter
counting labeled cells that exceeded the upper limit of the autofluores- genes were made in which either one or three copiescence of unlabeled cells (A). The mean fluorescence intensity (MFI)
of the AP-1/ets motifs or the corresponding sequenceswas calculated by subtracting the autofluorescence intensity from the
observed MFI of labeled cells (B). Results represent means 6 sd of containing mutations in either the AP-1 or ets were intro-
duplicate wells from four experiments. *P , 0.05 vs. control (time 0). duced upstream of the TATA box of the rat prolactin
gene promoter (Fig. 1) [14].
Transient expression assayMgCl2, 200 mmol/liter dNTPs, 0.125 mmol/liter of prim-
ers, and 1.25 U Taq DNA polymerase. After incubation Human mesangial cell lines at a density of 6 3 107 cells/
for 145 seconds at 958C, 36 cycles were performed for ml were transfected with 100 mg of supercoiled reporter
30 seconds at 958C, 30 seconds at 608C, and 60 seconds genes and 100 mg control plasmid of psv-b-galactosidase
at 728C. Twenty microliters of each PCR reaction were (Internal standard) by electroporation at 340 V and 125
subjected to electrophoresis in a 2% agarose gel. uF with a Gene Pulser (Bio-Rad, Hemel Hempstead,
Southern blot analysis and quantitative evaluation Herefordshire, UK). After electroporation, the cells
were placed in six-well plates with growth medium. Ap-Nucleic acids were transferred to a nylon membrane
(Boehringer Mannheim, Lewes, East Sussex, UK) and proximately 24 hours after replating, cells were washed
Ruan et al: Human mesangial cells and scavenger receptor444
Fig. 3. Specificity of the flow cytometric anal-
ysis of uptake of DiI-Ac-LDL in human mes-
angial cell lines (HMCLs). HMCLs were incu-
bated in serum-free medium (A–C) or serum-
free medium with 16 nmol/liter of phorbol
12-myristate 13-acetate (PMA; D–F ) for 72
hours, and then the medium was replaced by
fresh serum-free medium with 10 mg/ml unla-
beled Ac-LDL (A, D) or 10 mg/ml DiI-labeled
Ac-LDL (B, E) or 10 mg/ml DiI-labeled Ac-
LDL plus 1000 mg/ml of unlabeled Ac-LDL
(C, F) for three hours at 378C. Fluorescence
intensity per cell is shown on the x axis, and
the number of DiI-labeled cells is shown on
the y axis. The M range indicated in the histo-
grams was arbitrarily determined in each ex-
periment to calculate the percentage of la-
beled cells based on autofluorescence of the
unlabeled cells.
with PBS, and the medium was replaced by fresh serum- tab software. Data were considered significant if the P
value # 0.05.free RPMI medium in the presence or absence of differ-
ent concentrations of PMA or Ang II for various times.
The cells were then washed twice with PBS and lyzed RESULTS
using a lysis buffer (Promega). The luciferase and
We assessed the binding and internalization of DiI-b-galactosidase enzyme activity in the supernatants were
labeled Ac-LDL in HMCLs treated with PMA and Angassayed using Promega luciferase and b-galactosidase
II by FACS analysis. The parameters used to evaluateassay systems.
data were the percentage of fluorescent-positive cells
and the MFI of DiI-labeled cells. The results showedEffect of various signal transduction inhibitors on
that PMA and Ang II increased the percentage of DiI-PMA and Ang II-mediated activity of Scr promoter
labeled positive cells in a time-dependent manner (Fig.Using the transient expression assay system described
2A). We also investigated whether PMA and Ang II
earlier in this article, the reporter gene ESL was trans-
affected the density of Scr on HMCLs. The data showed
fected into HMCLs. Transfected cells were incubated that PMA and Ang II increased MFI in a time-dependent
for 24 hours in serum-free RPMI medium or serum-free manner (Fig. 2B), indicating an increased intracellular
medium with 16 nmol/liter of PMA or 1 mmol/liter of level of DiI-labeled Ac-LDL in HMCLs. This suggests
Ang II in the presence or absence of different signal that PMA and Ang II increases Scr density on HMCLs.
transduction pathway inhibitors: 25 mmol/liter W-7 (cal- The specificity of the analysis was confirmed by showing
modulin antagonist), 25 mmol/liter genistein (receptor that excess amounts of unlabeled Ac-LDL inhibited the
tyrosine kinase inhibitor), 100 nmol/liter calphostin C uptake of DiI-Ac-LDL (Fig. 3). These results suggest
(PKC inhibitor), 1 nmol/liter staurosporine (serine/thre- that the enhanced metabolism of Ac-LDL results from
onine kinase inhibitor), and 10 ng/ml pertussis toxin (G- an increase in both the number of Scr-positive cells and
protein inhibitor). Scr promoter activity was estimated Scr density in HMCLs.
by measuring luciferase luminescence. Staining of HMCLs with Oil Red O before (Fig. 4A)
and after PMA (Fig. 4B) and Ang II (Fig. 4C) stimulation
Data analysis showed that both PMA and Ang II increased the number
In all experiments, groups of data were evaluated for of intracellular Oil Red O-stained lipid droplets. The
stable cell line HMCL-Scr showed a stronger pattern ofsignificance by one-way analysis of variance using Mini-
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Fig. 4. Visualization of acetylated low density lipoprotein (Ac-LDL) uptake and lipid droplets in human mesangial cell lines (HMCLs) after
phorbol 12-myristate 13-acetate (PMA) or angiotensin II (Ang II) treatment. HMCLs were incubated for 72 hours in serum-free medium in the
absence (A) or presence (B) of 16 nmol/liter PMA or 1 mmol/liter of Ang II (C). The cells (A–C) and cultured HMCL-Scr (D) were further
incubated with 50 mg/ml Ac-LDL for 48 hours at 378C and then were examined for lipid inclusions by Oil Red O staining. For fluorescence
microscope examination, primary cultures of HMCs (E) and HMCLs (F ) were incubated with 16 nmol/liter PMA for three days and were then
treated with 1 mmol/liter of colchicine for 14 hours and were finally labeled with 10 mg/ml DiI-Ac-LDL for five hours at 378C. The cells were fixed
and examined for fluorescence. The results are typical of those observed in four experiments.
Oil Red O staining (Fig. 4D), which confirmed that Scr some separation. The synchronized HMCLs and primary
cultures of HMCs were used to evaluate DiL-Ac-LDLhad a functional relevance in mesangial cells cultured in
the appropriate environment. The uptake of DiI-Ac- uptake. Result showed that the majority of cells dis-
played high fluorescence after stimulation by PMA.LDL by HMCLs and primary cultures of HMCs follow-
ing PMA stimulation was also visualized by fluorescence However, some PMA-treated cells were low fluorescent
or nonfluorescent, even after synchronization with col-microscopy. HMCLs and primary cultures of HMCs
were treated by 16 nmol/liter of PMA for 72 hours and chicine (Fig. 4 E, F). These data suggest that not all cells
in this population express Scr to the same degree whenwere then arrested by incubation with colchicine, which
maintains mitotic cells in metaphase by blocking the stimulated by PMA and that the nonhomogeneous be-
havior of HMCLs with respect to DiI-Ac-LDL uptakespindle apparatus production needed for the chromo-
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Fig. 5. Time-dependent expression of scav-
enger receptor (Scr) mRNA in response to
phorbol 12-myristate 13-acetate (PMA) and
angiotensin II (Ang II ). Human mesangial cell
lines (HMCLs) were incubated in serum-free
medium containing 16 nmol/liter of PMA or
1 mmol/liter of Ang II for different periods of
time (0, 24, 48, and 72 hours). (A) Scr mRNA
expression was examined using reverse tran-
scription-polymerase chain reaction followed
by Southern blotting as described in Methods.
(B) The histogram represent means 6 sd of
the densitometric scans of the Scr mRNA
band from three experiments, normalized by
comparison with GAPDH mRNA, and ex-
pressed as a percentage of time 0.
is not a function of the cell cycle, with temporary suspen- HMCLs. The transfected HMCLs were stimulated by dif-
ferent concentrations of PMA and Ang II at various times,sion of the cells during certain phases of the cycle. It is
also excluded that heterogeneity results from different and the promoter activity was measured. The results
showed that PMA and Ang II induced Scr promoter activ-functional specificity within the cell line.
Reverse transcription-PCR, followed by Southern ity in a time- and dose-dependent manner, which was
consistent with the induction of Scr mRNA (Fig. 7 A, B).blotting, showed that HMCLs had a low Scr mRNA
level under normal tissue culture conditions. However, To determine the role of signal transduction pathways
in the regulation of Scr gene expression in PMA or AngHMCLs expressed an inducible form of Scr when stimu-
lated by PMA and Ang II. PMA (16 nmol/liter) induced II-stimulated HMCLs, we evaluated the effects of vari-
ous signal transduction pathway inhibitors on Scr tran-Scr expression in a time-dependent manner. Ang II (1
mmol/liter) also induced Scr expression (Fig. 5 A, B). scription using the luciferase system. At noncytotoxic
concentrations of inhibitors, we observed that the pro-Both PMA at 1.6 to 160 nmol/liter and Ang II at 1 to 1000
nmol/liter induced Scr mRNA expression in HMCLs in moter activity of Scr in PMA or Ang II-treated HMCLs
in the presence of PKC inhibitor (calphostin C) or cal-a dose-responsive manner (Fig. 6 A, B).
To investigate whether enhanced Scr mRNA resulted modulin inhibitor (W-7) was significantly lower than in
the absence of calphostin C or W-7, suggesting that bothfrom increased gene transcription in HMCLs, we ana-
lyzed the Scr promoter activity. The reporter gene (ESL) PKC and calmodulin pathways were involved in Scr up-
regulation. Additionally, a serine/threonine kinase inhib-containing the full Scr promoter was transfected into
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Fig. 6. Effect of different concentrations of
phorbol 12-myristate 13-acetate (PMA) and
angiotensin II (Ang II) on scavenger receptor
(Scr) mRNA expression. Human mesangial
cell lines (HMCLs) were incubated in serum-
free medium (control) or serum-free medium
containing various concentrations of PMA
(1.6, 16, and 160 nmol/liter) for 72 hours or
Ang II (10, 100, and 1000 nmol/liter) for 48
hours. (A) Scr mRNA expression was exam-
ined using reverse transcription-polymerase
chain reaction (RT-PCR) followed by South-
ern blotting as described in the Methods sec-
tion. (B) The histogram represent means 6
sd of the densitometric scans of the Scr
mRNA band from three experiments, normal-
ized by comparison with GAPDH mRNA,
and expressed as a percentage of control.
itor (staurosporine) significantly inhibited Scr promoter both AP-1 and ets motifs are necessary response elements
activity induced by PMA, suggesting that the serine/ for gene transcription induced by PMA (Fig. 8). How-
threonine kinase pathway was also involved in up-regula- ever, the reporter gene containing three copies of AP-1/
tion of Scr induced by PMA (Table 1). ets responsive elements responded slightly to Ang II
The molecular mechanism of gene transcription was stimulation, suggesting that AP-1/ets motifs are not spe-
further investigated using several reporter gene constructs cific response elements for Ang II (Fig. 8).
described in Figure 1. Functional analysis showed that the
minimal prolactin promoter exhibited very little activity
DISCUSSIONeither before or after PMA and Ang II treatment (Fig. 8).
Scavenger receptors mediate the uptake of modifiedHowever, when either one or three copies of the AP-1/ets
LDLs by macrophages. The accumulation of lipids viamotifs were introduced upstream of the minimal prolactin
this process is thought to lead to foam cell formation inpromoter, this promoter could respond to PMA stimula-
developing atherosclerotic plaques and in glomeruloscle-tion in HMCLs. Three copies of the AP-1/ets motifs in-
rosis [25–27]. These experiments showed that PMA andcreased basal activity by twofold to threefold in response
Ang II increased Scr protein activity by increasing bothto PMA stimulation. This suggested that AP-1/ets motifs
the number of Scr-positive cells and the density of Scrare specific response elements for PMA stimulation
per cell in HMCLs. We also analyzed the mRNA expres-(Fig. 8). Mutation of either the AP-1 or the ets motifs
decreased its ability to respond to PMA, suggesting that sion of Scr and showed that there was an inducible ex-
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II contributes to atherogenesis in vivo at least in part
through the induction of Scr. This may explain why
HMCs that have not previously been shown to express
Scr in normal culture can express Scr in vivo [10, 12].
There is some degree of heterogeneity of Scr expres-
sion within the HMCL population. A proportion of the
cell population was negative for receptor, as judged by
cell-sorting analysis and by fluorescence microscopy, re-
gardless of the length of exposure to PMA. This may
explain several aspects of the phenotypical conversion of
HMCs, including cell proliferation, transformation from
smooth muscle cells to phagocytes, and foam cell forma-
tion. Synchronized HMCLs and primary cultures of
HMCs after colchicine arrest also showed a nonhomoge-
neous staining pattern with DiL-Ac-LDL, suggesting
that the nonhomogeneous behavior of HMCLs with re-
spect to DiI-Ac-LDL uptake did not result from different
functional specificities within the cell line used nor was
it a function of the cell cycle, with temporary suspension
of the cells during certain phases of the cycle.
The mechanism by which PMA induces the expression
of Scr remains unclear. Both PMA and Ang II are activa-
tors of the PKC pathway. The experiments using signal
transduction pathway inhibitors showed that the PKC
and calmodulin pathways were involved in the induction
of Scr by PMA and Ang II during the first 24 hours of
culture. PMA-induced down-regulation of PKC has been
examined in various cell types in long-term incubation.
Different cell lines displayed a range of sensitivities to
tetradecanoyl phorbol acetate (TPA)-induced down-reg-
ulation of PKC, suggesting that there could be cell-type–
specific differences in the pattern of down-regulation
[29]. In these HMCL experiments, we could not exclude
PMA-induced down-regulation of PKC. However, the
activation of the PKC pathway may be an early event,Fig. 7. Response of Scr promoter to phorbol 12-myristate 13-acetate
(PMA) and angiotensin II (Ang II). Human mesangial cell lines and other signal transduction pathways may be involved
(HMCLs) were transfected with ESL construct, as a internal standard, during long-term differentiation.
using a psv-b-galactosidase plasmid. The transfected cells were cultured
Additionally, we focused on the molecular mechanismin a standard RPMI medium containing 5% fetal calf serum (FCS).
After 24 hours, the cells were incubated in serum free medium with 16 of Scr up-regulation by PMA and Ang II. A reporter
nmol/liter of PMA (d) or 1 mmol/liter of Ang II (j) for different times gene containing the Scr promoter (2696 to 146) was
(0, 2, 4, 8, 24, and 48 hr; time 0 as a control; A) or the cells were incubated
transfected into HMCLs. The results showed that PMAin serum-free medium (control) or serum-free medium containing various
concentrations of PMA (0.016, 0.16, 1.6, 16, and 160 nmol/liter; d) or and Ang II could increase Scr promoter activity in a dose-
Ang II (0.1, 1, 10, 100, and 1000 nmol/liter; j) for 24 hours (B). Lucifer- responsive manner. This result suggests that PMA and
ase activity was measured and normalized by comparison with b-galac-
Ang II increase Scr expression by enhancing Scr genetosidase activity. Results represent the mean 6 sd of duplicate determi-
nations from six experiments, which were normalized to their respective transcription. The Scr 59 upstream (24.1 kb to 146) of
control (100%). *P , 0.001 vs. control. genomic DNA contains several copies of binding motifs
of AP-1/ets transcription factors. To examine further the
relative roles of the AP-1/ets motifs in mediating PMA
and Ang II-dependent transcriptional activation, a mini-pression of Scr mRNA in cultures of HMCLs. These
mal prolactin gene promoter was used, which exhibitedresults imply that there is limited expression of Scr under
very little activity either before or after PMA and Ang IIphysiological conditions, but when HMCs were stimu-
treatment. Luciferase reporter constructs were made inlated by PMA and Ang II, they expressed an inducible
which either one or three copies of the AP-1/ets motifsScr. Ang II has been shown to have an important role in
or the corresponding sequences containing mutations inprogressive glomerulosclerosis in various animal models
and clinical studies [28]. We therefore suggest that Ang either the AP-1 or ets were introduced upstream of a
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Table 1. Effects of phorbol 12-myristate 13-acetate (PMA) and angiotensin II (Ang II) on scavenger receptor (Scr) promoter activity in
the presence of various signal transduction pathway inhibitors
Relative Scr promoter–luciferase activity
Treatment Control PMA Ang II
No inhibitor 100 66.32 195.92620.7 172.20613
Calmodulin inhibitor (w-7) 100 615.71 134.66618.92b 119.68616.81a
Tyrosine kinase inhibitor (genistein) 100 610.86 253.04644.29 226.44661.57
PKC inhibitor (calphostin C) 100 618.39 148.53630.50a 124.65621.52a
Serine/threonine kinase inhibitor (staurosporine) 10066.91 164.76616.69a 158.86618.71
G-protein inhibitor (pertussis toxin) 100 615.13 190.88641.36 176.86649.61
a P , 0.05, b P , 0.001
Fig. 8. Functional analysis of the Scr promoter and AP-1/ets motifs in the context of the minimal prolactin gene promoter. The reporter gene
constructs shown in Figure 1 were transfected into human mesangial cell lines (HMCLs). Transfected cell were incubated in serum-free RPMI
medium in the absence (control) or presence of 16 nmol/liter phorbol 12-myristate 13-acetate (PMA) or 1 mmol/liter angiotensin II (Ang II) for
24 hours, and the promoter activity was determined. Results represent the mean of duplicate determinations from six experiments.
minimal promoter derived from the rat prolactin gene. induces Scr promoter activity by increasing the binding
of AP-1/ets transcription factors to the Scr promoterUsing this established method, Wu et al reported that
combinatorial interactions between AP-1 and ets domain region and that AP-1/ets transcription factors are neces-
sary for Scr expression induced by PMA in HMCLs.proteins contribute to the developmental regulation of
the macrophage Scr gene in the THP-1 cell line [14]. The reporter gene containing three copies of AP-1/ets
responsive elements responded slightly to Ang II stimu-AP-1/ets activity could be induced by and were necessary
for PMA-induced monocyte differentiation [14]. Our re- lation, suggesting that AP-1/ets motifs are not specific
response elements for Ang II. This probably impliessults showed that there was a similar regulatory effect
of AP-1/ets in HMCLs. AP-1/ets motifs were specific that different transcription factors are involved in Scr
induction induced by PMA and Ang II.response elements to PMA stimulation in HMCLs. A
mutation of either the AP-1 or the ets motifs decreased AP-1 proteins regulate the expression of a diverse set
of immediate/early genes that exhibit very rapid andits ability to respond to PMA, suggesting that AP-1/ets
motifs are necessary response elements for gene expres- transient transcriptional responses to signals transmitted
from cell surface receptors [30]. These immediate re-sion induced by PMA. These results imply that PMA
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phage oxidation of low density lipoprotein generates a modifiedsponses reflect post-translational modifications of AP-1
form recognized by the scavenger receptor. Arteriosclerosis 6:505–
proteins, which have been particularly well studied in the 510, 1986
case of c-jun [31, 32]. They may increase transcriptional 4. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Haya-
kawa I, Kanamori H, Aburatani H, Takaku F, Suzuki H, Kobaractivity independent of new protein synthesis [31]. In
I, Miyai T, Takahashi K, Cohen EH, Wydro R, Housman DE,contrast to immediate/early genes, Moulton et al re- Kodama T: Human macrophage scavenger receptors: Primary
ported that TPA maximally stimulated macrophage Scr structure, expression, and localization in atherosclerotic lesions.
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did not become maximal until 24 hours following PMA 1423, 1991
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